Iv-thiobufluatg-mud (b.2.4)-v2.0

IV Thiotepa/Busulfan/Fludarabine/ATG for Unrelated Donor Allograft

Acute myeloid leukaemia, acute lymphoblastic leukaemia, non-Hodgkin’s lymphoma: for unrelated
donor allogeneic transplants
• Ensure pre-transplant investigations are carried out as per protocol B3.10b • Ensure patient has triple or double lumen Hickman line insitu. • Ensure results of pre-transplant investigations are checked by a Haematology SpR and recorded in • Haematology SpR to complete electronic BMT front sheet and secretary to distribute and file in • Prescribe chemotherapy and supportive treatment at least 5 days before admission • Send NHSBT Request form 2E (MUD) to NHSBT at least 7 working days before the planned collection date and ensure a copy is placed in the medical notes. • Ensure donor clearance is obtained, reviewed and documented in recipient’s notes prior to • Ensure that the blood bank is notified that the patient is to receive irradiated blood products from the start of conditioning (see protocol on irradiated blood products) • Day -9: Ensure a pregnancy test is carried out on all women of child-bearing potential unless they have been sterilized or have undergone a hysterectomy, document results in medical notes. This is a controlled document and therefore must not be changed

Encourage 3L oral fluids daily, give IV if oral intake insufficient.
Nurses: Ensure flush volumes are included in rate and volume calculations, i.e. drug and flush should
be completed within prescribed administration time.
Day -9 to +30
Continuous infusion 200 units / kg over 48 hours (VOD

Day -8 to -7
5 mg/kg/iv/d over 4 hours in 500ml normal saline, via a 0.22
micron filter

Day –6 to – 4
3.2 mg/kg/iv/d in a single dose. 0.9% normal saline: Final
concentration 0.5mg/ml Give over 3 hours. This is a controlled document and therefore must not be changed
2.5 mg/one time only/iv in 100ml sodium chloride 0.9% over 1 hour through a 0.22 micron filter. Flush
with sodium chloride 0.9%
Test dose must be supervised by a doctor with
adrenaline, chlorphenamine, hydrocortisone drawn up
Each ATG dose must be completed within 18 hours of being
made up.
Platelet count must be maintained > 30 but platelet transfusion
should not be given concurrently with ATG because of its anti-
platelet activity.
If possible avoid giving more than 1 unit of red cells each day
of ATG to help avoid the risk of fluid overload.

Day -5 to -2
1mg/kg iv bd (NOTE Day -6: only evening dose to be given:
Day -2 only morning dose to be given)
in 100ml sodium chloride 0.9% over 15 minutes
Day -5 to -3
50mg/m2/d iv in 100ml 0.9% sodium chloride over 30 minutes
Day -5 to -2
10mg iv bolus 30mins pre ATG
1g po 30mins pre ATG
2mg/kg iv od in 500ml sodium chloride 0.9% OVER 8 hours
Give hydrocortisone 100mg iv, chlorphenamine (formerly chlorpheniramine) 10mg iv 15 minutes before cell infusion. Pentamidine
300mg iv
in 100ml sodium chloride 0.9% over 1 hour
15mg/m2 /iv bolus
(at least 24hr post bone marrow/stem cell infusion) Day +3,+6,
10mg/m2/iv bolus
(Day 11 dose omitted for severe mucositis, check with This is a controlled document and therefore must not be changed

Refer to nursing care plan N.86a, N86b
Refer to nursing care plan N.51 or N.18

Day –8 to -3


2mg po nocte from day –7 to day – 3 inclusive Norethisterone
5-10mg po tds from day 0 until platelets >50x109/l (menstruating women only) Fluconazole
50mg od po from day 0 until neutrophils >1.0x109/l
(or longer if on steroids ) (NOTE: INTERACTION WITH

For CMV Prophylaxis
If either donor or recipient or both are CMV + then:
500mg /m2 tds iv or 800mg po qds day -7 to day +30 then
800mg po qds for 3 months, then 200mg tds for further 3 months if
VZV positive

If both donor and recipient are CMV negative then consider
HSV/VZV Prophylaxis
Aciclovir dose is 250mg iv tds or 200mg po tds
Duration of treatment depends on HSV and VZV status of recipient:
HSV neg and VZV neg no aciclovir needed
HSV pos and VZV neg treat for 3 months HSV pos and VZV pos treat for 6 months Ciclosporin
1.5mg/kg iv bd - total dose 3mg/kg/day (adjust for renal toxicity) in 20 - 100ml sodium chloride 0.9% over 2- 4hr from day –1. See protocol.
Change to po prior to discharge. See Medication on Discharge
200iu/kg/48hr infusion in 48 ml sodium chloride 0.9% infused at 1ml/hr from admission to day +30 or discharge Allopurinol
300mg od for 7 days only in patients with acute leukaemia who are not in remission. Omeprazole
20mg od from start of conditioning until platelet count >50x109/l This is a controlled document and therefore must not be changed

Stop when neutrophils >1x 109/l (may be longer if patient on Co-trimoxazole
960mg daily Mon, Wed, Fri: start when neutrophils >1.0 x 109/l and continue until one month after immunosuppressive therapy stopped. If allergic to co-trimoxazole, pentamidine 4mg/kg iv monthly. When co-trimoxazole is stopped, start Penicillin V 250mg bd. Aciclovir
Depends on CMV/ HSV/ VZV status. Refer to page 3 of this protocol. Omeprazole


On discharge the patient should be prescribed an oral dose of two times
the last intravenous dose. See protocol. Check with registrar or
Consider tailing from day +120 in the absence of GvHD.
Penicillin V
250mg bd to start on discharge and continue for life.
Sanz J, Boluda JC, Martín C, González M, Ferrá C, Serrano D, de Heredia CD, Barrenetxea C,
Martinez AM, Solano C, Sanz MA, Sanz GF.Single-unit umbilical cord blood transplantation from
unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and
ATG as myeloablative conditioning regimen. Bone Marrow Transplant. 2012 Feb 13
These processes are subject to the OxBMT audit programme.

Dr Andy Peniket and Prof. Vanderson Rocha

Patient file, JACIE electronic document file
Version Review date
Dr Andy Peniket, Prof Vanderson New document Thiotepa, Pen V for life from discharge. This is a controlled document and therefore must not be changed

Source: http://clsmac70.ndcls.ox.ac.uk/tssg-haematology/bmt/allo/iv-thiobufluatg-mud.pdf

Appraisal of the human resources for health situation in tanzania

Dominick & Kurowski, January 2005 Human resources for health - an appraisal of the status quo in Tanzania mainland Anna Dominick1 and Christoph Kurowski2,3 1 Ifakara Health Research and Development Centre 3 London School of Hygiene & Tropical Medicine Dominick & Kurowski, January 2005 ACKNOWLEDGEMENTS This study was funded by the World Bank. The findings, interpretatio

Microsoft word - documento5

The danger of dysteachia Published in: Jornal do Professor ● Year 10 nº 0 ● February 2006 ● pg. 9 Educators be careful! There seems to be a worldwide outbreak of dysteachia in schools everywhere. Dystechia is a teaching disability deomonstrated by an educator’s cynical view on education and conformity to an inadaquete system. The word dsysteachia is derived from the greek words

Copyright © 2010-2014 Medical Pdf Finder